Al Sandrock to step down as Voyager CEO; Insmed adds Paul Hudson to board

→ Al Sandrock is calling it quits as CEO of Voyager Therapeutics in the first quarter next year, but he will stay on the board. Chief business and operating officer Robin Swartz, a Sanofi Genzyme ...